NCT01487343已完成不适用
A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 79
- 试验地点
- 1
- 主要终点
- adherence to oral chemotherapy
研究概览
简要总结
The purpose of this study is to identify what makes it easier and what makes it harder to take oral chemotherapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of primary breast cancer or gastrointestinal cancer
- •Currently prescribed capecitabine
- •Age 21 years or older
- •Able to understand written and oral English
排除标准
- •Major psychopathology or cognitive impairment likely in the judgment of the research staff to interfere with the participation or completion of the protocol.
结局指标
主要结局
adherence to oral chemotherapy
时间窗: 1 year
Participation in the study entails completion of five short questionnaires related to the medication adherence (Medication Adherence Questionnaire), beliefs about medication (Beliefs about Medications Questionnaire), side effect experience (Frequency, Intensity, and Burden of Side Effects Rating), self-efficacy (Self-efficacy for Appropriate Medication Use) and satisfaction with medication information (Satisfaction with Information about Medicines Scale) as well as a demographic and treatment data sheet.
次要结局
- improve the care of patients(1 year)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1)E.Coli InfectionsNCT04087681MJM Bonten4,479
已完成
不适用
Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part IIDepressionAnxiety DisordersNCT05555875Brigham and Women's Hospital76
已完成
不适用
Determinants of Thyroid Surgery OutcomesThyroid DiseaseNCT02813733Hospices Civils de Lyon3,500
已完成
不适用
Feasibility Pilot Exploring Variability in Biomarkers and PROs in AMLAcute Myeloid Leukemia (AML)NCT04908852Dana-Farber Cancer Institute10
已完成
不适用
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical CancerRecurrent Cervical CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Uterine Corpus SarcomaStage I Uterine Corpus CancerStage I Uterine SarcomaStage IA Cervical CancerStage IB Cervical CancerStage II Uterine Corpus CancerStage II Uterine SarcomaStage IIA Cervical CancerStage IIB Cervical CancerStage III Cervical CancerStage III Uterine Corpus CancerStage III Uterine SarcomaStage IV Uterine Corpus CancerStage IV Uterine SarcomaStage IVA Cervical CancerStage IVB Cervical CancerNCT01098630Gynecologic Oncology Group778